Edinburgh Research Explorer

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned

Research output: Contribution to journalArticle

  • N R Wray
  • M L Pergadia
  • B W J H Penninx
  • D R Nyholt
  • S Ripke
  • K A McGhee
  • J H Smit
  • J J Hottenga
  • G Willemsen
  • C M Middeldorp
  • E J C de Geus
  • C M Lewis
  • P McGuffin
  • I B Hickie
  • E J C G van den Oord
  • S Macgregor
  • B P McEvoy
  • E M Byrne
  • S E Medland
  • D J Statham
  • A K Henders
  • A C Heath
  • G W Montgomery
  • N G Martin
  • D I Boomsma
  • P F Sullivan

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/

    Final published version, 507 KB, PDF-document

Original languageEnglish
Pages (from-to)36-48
Number of pages13
JournalMolecular Psychiatry
Volume17
Issue number1
DOIs
StatePublished - Jan 2012

Abstract

Major depressive disorder (MDD) is a common complex disorder with a partly genetic etiology. We conducted a genome-wide association study of the MDD2000+ sample (2431 cases, 3673 screened controls and >1 M imputed single-nucleotide polymorphisms (SNPs)). No SNPs achieved genome-wide significance either in the MDD2000+ study, or in meta-analysis with two other studies totaling 5763 cases and 6901 controls. These results imply that common variants of intermediate or large effect do not have main effects in the genetic architecture of MDD. Suggestive but notable results were (a) gene-based tests suggesting roles for adenylate cyclase 3 (ADCY3, 2p23.3) and galanin (GAL, 11q13.3); published functional evidence relates both of these to MDD and serotonergic signaling; (b) support for the bipolar disorder risk variant SNP rs1006737 in CACNA1C (P=0.020, odds ratio=1.10); and (c) lack of support for rs2251219, a SNP identified in a meta-analysis of affective disorder studies (P=0.51). We estimate that sample sizes 1.8- to 2.4-fold greater are needed for association studies of MDD compared with those for schizophrenia to detect variants that explain the same proportion of total variance in liability. Larger study cohorts characterized for genetic and environmental risk factors accumulated prospectively are likely to be needed to dissect more fully the etiology of MDD.

    Research areas

  • Adenylate Cyclase, Adolescent, Adult, Calcium Channels, L-Type, Depressive Disorder, Major, Female, Galanin, Genetic Predisposition to Disease, Genome-Wide Association Study, Genotype, Humans, Male, Middle Aged, Odds Ratio, Polymorphism, Single Nucleotide, Principal Component Analysis, Sex Factors, Young Adult

Download statistics

No data available

ID: 15396681